Serial changes in circulating concentrations of soluble CD40 ligand and C-reactive protein in patients with unstable angina undergoing coronary stenting -Role of inflammatory mediators in predicting late restenosis

Circulation Journal

Volumn 69, Issue 8, 2005, Pages 890-895

  Yip, Hon Kan ^a   Wu, Chiung Jen ^a   Yang, Cheng Hsu ^a   Chang, Hsueh Wen ^a,b   Fang, Chih Yuan ^a   Hung, Wei Chin ^a   Hang, Chi Ling ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

Author keywords

Coronary stenting; Inflammatory mediators; Restenosis; Unstable angina

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CD40 LIGAND;

ADULT; AGED; ARTICLE; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORONARY STENT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RESTENOSIS; STATISTICAL SIGNIFICANCE; UNSTABLE ANGINA PECTORIS;

AGED; ANGINA, UNSTABLE; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CD40 LIGAND; CORONARY RESTENOSIS; GRAFT OCCLUSION, VASCULAR; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; STENTS;

EID: 23744450271     PISSN: 13469843     EISSN: None     Source Type: Journal    
DOI: 10.1253/circj.69.890     Document Type: Article

References (36)

1. Popma JJ, Califf RM, Topol EJ. Clinical trials of restenosis after coronary angioplasty. Circulation 1991; 84: 1426-1436.
2. Yip HK, Wu CJ, Yang CH, Chang HW, Chen SM, Hung WC, et al. Delayed post myocardial infarction invasive measures, helpful or harmful? A subgroup analysis. Chest 2004; 126: 38-46.
3. Ross R. The pathogenesis of atherosclerosis: A perspective for 1990s. Nature 1993; 362: 801-809.
4. van der Wal AC, Becker AE, van der Loos CM, Das PK. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 1994; 89: 36-44.
5. Ross R. Atherosclerosis: An inflammatory disease. N Engl J Med 1999; 340: 115-126.
6. Pasceri V, Chang J, Willerson JT, Yeh ETH. Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cell by anti-atherosclerosis drugs. Circulation 2001; 103: 2531-2534.
7. Biasucci LM, Vitelli A, Liuzzo G, Altamura S, Caligiuri G, Monaco C, et al. Elevated concentrations of interleukin-6 in unstable angina. Circulation 1996; 94: 874-877.
8. Liuzzo G, Biascucci LM, Gallimore JR, Grillo RT, Rebuzzi AG, Pepys MB, et al. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Eng J Med 1994; 331: 417-424.
9. Biasucci LM, Liuzzo G, Grillo RL, Caligiuri G, Rebuzzi AG, Buffon A, et al. Elevated concentrations of C-reactive protein at discharge in patients with unstable angina predict recurrent instability. Circulation 1999; 99: 855-860.
10. Buffon A, Liuzzo G, Biasucci LM, Pasqualetti P, Ramazzotti V, Rebuzzi AG, et al. Preprocedural serum concentrations of C-reactive protein predict early complications and late restenosis after coronary angioplasty. J Am Coll Cardiol 1999; 34: 1512-1521.
11. Cipollone F, Ferri C, Desideri G, Paloscia L, Materazzo G, Mascellanti M, et al. Preprocedural concentration of soluble CD40L is predictive of enhanced inflammatory response and restenosis after coronary angioplasty. Circulation 2003; 108: 2776-2782.
12. Choi H, Cho DH, Shin HH, Park JB. Association of high sensitivity C-reactive protein with coronary heart disease prediction, but not with carotid atherosclerosis, in patients with hypertension. Circ J 2004; 68: 297-303.
13. Mueller C, Buettner HJ, Hodgson JM, Marsch S, Perruchoud AP, Roskamm H, et al. Inflammation and long-term mortality after non-ST elevation acute coronary syndrome treated with a very early invasive strategy in 1042 consecutive patients. Circulation 2002; 105: 1412-1415.
14. Yip HK, Hang CL, Fang CY, Hsieh YK, Yang CH, Hung HW, et al. Level of high-sensitivity C-reactive protein is predictive of 30-day outcomes in patients with acute myocardial infarction undergoing primary coronary intervention. Chest 2005 (in press).
15. Henn V, Slupsky JR, Grafe M, Anagnostopoulos L, Forster R, Muller-Berghaus G, et al. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 1998; 391: 591-594.
16. Mach F, Schonbeck U, Sukhova GK, Bourcier T, Bonnefoy JY, Pober JS, et al. Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: Implication CD40-CD40 ligand signaling in atherosclerosis. Proc Natl Acad Sci USA 1997; 94: 1931-1936.
17. Aukrust P, Muller F, Ueland T, Berget T, Aaser E, Brunsvig A, et al. Enhanced concentrations of soluble and membrane-bound CD-40 ligand in patients with unstable angina. Circulation 1999; 100: 614-620.
18. Hermiller JB, Cusma JT, Spero LA, Fortin DF, Harding MB, Bashore TM. Quantitative and qualitative coronary angiographic analysis: Review of methods, utility, and limitations. Cathet Cardiovasc Diagn 1992; 25: 110-131.
19. Braunwald E. Unstable angina: A classification. Circulation 1989; 80: 410-414.
20. Andre P, Nannizzi-Alaimo L, Prasad SK, Phillips DR. Platelet-derived CD40L: The switch-hitting player of cardiovascular disease. Circulation 2002; 106: 896-899.
21. Burke AP, Tracy RP, Kolodgie F, Malcom GT, Zieske A, Kutys R, et al. Elevated C-reactive protein values and atherosclerosis in sudden coronary death: Association with different pathologies. Circulation 2002; 105: 2019-2023.
22. Yip HK, Wu CJ, Chang HW, Yang CH, Yeh KH, Chua S, et al. Levels and values of serum high-sensitivity C-reactive protein within six hours after the onset of an acute myocardial infarction. Chest 2004; 126: 1417-1422.
23. Yip HK, Chen SS, Liu JS, Chang HW, Kao YF, Lan MY, et al. Serial changes in platelet activation in patients after ischemic stroke: Role of pharmacodynamic modulation. Stroke 2004; 35: 1683-1687.
24. Li SH, Szmitko PE, Weisel RD, Wang CH, Fedak PWM, Li RK, et al. C-reactive protein upregulates complement-inhibitory factors in endothelial cells. Circulation 2004; 109: 833-836.
25. Le J, Vilcek J. Interleukin 6: A multifunctional cytokine regulating immune reactions and the acute phase protein response. Lab Invest 1989; 61: 588-602.
26. Schonbeck U, Varo N, Libby P, Buring J, Rider PM. Soluble CD40L and cardiovascular risk in women. Circulation 2001; 104: 2266-2268.
27. Ichihara Y, Ohno J, Suzuki M, Anno T, Sugino M, Nagata K. Higher C-reactive protein concentration and white blood cell count in subjects with more coronary risk factors and/or lower physical fitness among apparently healthy Japanese. Circ J 2002; 66: 677-684.
28. Zhou YF, Csako G, Grayston JT, Wang SP, Yu ZX, Shou M, et al. Lack of association of restenosis following coronary angioplasty with elevated C-reactive protein concentrations or seropositivity to Chlamydia pneumoniae. Am J Cardiol 1999; 84: 595-598.
29. Gaspardone A, Crea F, Versaci F, Tomai F, Pellegrino A, Chiariello L, et al. Predictive value of C-reactive protein after successful coronary-artery stenting in patients with unstable angina. Am J Cardiol 1998; 82: 515-518.
30. Dibra A, Mehilli J, Braun S, Hadamitzky M, Baum H, Dirschinger J, et al. Association between C-reactive protein concentrations and subsequent cardiac events among patients with stable angina treated with coronary artery stenting. Am J Med 2003; 114: 715-722.
31. Kornowski R, Mintz GS, Kent KM, Pichard AD, Satler LF, Bucher TA, et al. Increased restenosis in diabetes mellitus after coronary interventions is due to exaggerated intimal hyperplasia: A serial intravascular study. Circulation 1997; 95: 1366-1369.
32. Serruys PW, Degertekin M, Tanabe K, Abizaid A, Sousa JE, Colombo A, et al. Intravascular ultrasound findings in the multicenter, randomized, double-blinded RAVEL trial. Circulation 2002; 106: 798-803.
33. Hoffmann R, Mintz GS, Dussailant GR, Popma JJ, Pichard AD, Satler LF, et al. Patterns and mechanisms of in-stent restenosis: A serial intravascular ultrasound study. Circulation 1996; 94: 1247-1254.
34. Morice MC, Serruys PW, Sausa JE, Fajadet J, Hayashi EB, Perin M, et al. A randomized comparison of a sirolimus-eluting stenting with a standard stent for coronary revascularization. N Engl J Med 2002; 346: 1773-1780.
35. Bauters C, Hubert E, Prat A, Bougrimi K, Van Belle E, McFadden EP, et al. Predictors of restenosis after coronary stent implantation. J Am Coll Cardiol 1998; 31: 1291-1298.
36. Crisby M, Nordin-Fredriksson G, Shah PK, Yano J, Zhu J, Nilsson J. Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinase, and cell death in human carotid plaques: Implication for plaque stabilization. Circulation 2001; 103: 926-933.